html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

Aims

Identification of novel genetic variants that predispose to cancer by state-of-the-art omics analyses of hereditary cancer-suspected individuals.
Understanding the mechanisms that underly cancer development by genomic analyses and model systems.
Translating findings from research to clinical practise to improve the care for individuals with cancer.

go to main content

Go to Radboudumc Radboudumc

Research group Cancer genomics

Welcome to Research

type a search term here ...

information on how Radboudumc conducts research →
opportunities for my career within Radboudumc research →
opportunities to participate or invest in Radboudumc research →

Research Research groups Cancer genomics

About Cancer genomics

We focus on the genetic predispositions and mutational processes that underly cancer development, especially in the context of cancer development at an early age in Iife and concerning the development of multiple primary tumors throughout the life of a single individual.

Research group leader

dr. Richarda de Voer

Aims

See our most important goals.

Publications

See some of our most important scientific articles.

Listen

Publications

See the publication list of the research group leader on Web of Science.

Profile page

See the group leader's profile.

see page

Research programs

Programs that are connected to this research group.